Phase 2 Peripheral T-cell Lymphomas Clinical Trials

2 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–2 of 2 trials

Recruiting

Phase 2

Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma

Lymphoproliferative DisordersImmune System DiseasesPeripheral T-cell Lymphomas

National Cancer Institute (NCI)330 enrolled2 locationsNCT03922724

Recruiting

Phase 1Phase 2

Azacytidine Plus CAOLD Regimen in Relapsed/Refractory Peripheral T-Cell Lymphomas

Relapsed Peripheral T-Cell LymphomasRefractory Peripheral T-Cell Lymphomas

Navy General Hospital, Beijing52 enrolled1 locationNCT06176027